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Curcuma longa, which contains curcumin as a major constituent, has been shown many pharmacological 
effects, but it is limited using in clinical due to low bioavailability. In this study, we developed a phytosome 
curcumin formulation and evaluated the hepatoprotective effect of phytosome curcumin on paracetamol 
induced liver damage in mice. Phytosome curcumin (equivalent to curcumin 100 and 200 mg/kg body 
weight) and curcumin (200 mg/kg body weight) were given by gastrically and toxicity was induced by 
paracetamol (500 mg/kg) during 7 days. On the final day animals were sacrificed and liver function markers 
(ALT, AST), hepatic antioxidants (SOD, CAT and GPx) and lipid peroxidation in liver homogenate 
were estimated. Our data showed that phytosome has stronger hepatoprotective effect compared to 
curcumin-free. Administration of phytosome curcumin effectively suppressed paracetamol-induced liver 
injury evidenced by a reduction of lipid peroxidation level, and elevated enzymatic antioxidant activities 
of superoxide dismutase, catalase, glutathione peroxidase in mice liver tissue. Our study suggests that 
phytosome curcumin has strong antioxidant activity and potential hepatoprotective effects.
Uniterms: Curcumin/effects. Curcumin/antioxidant activity. Curcuma longa. Phytosome. 
Hepatoprotective.
INTRODUCTION
Curcumin is a polyphenol extracted from the 
rhizomes of Curcuma longa. It has a yellow color, and 
traditional used in many foods. Curcumin has been 
shown many beneficial biological activities including 
antioxidant, anti-inflammatory, anticoagulant, antitumor 
and hepatoprotective activities (Anand et al., 2008) . 
However, curcumin has a limited to use as a drug to treat 
the disease because of its poor solubility in water and its 
low oral bioavailability (Prasad, Tyagi, Aggarwal, 2014; 
Siviero et al., 2015). Therefore, it is needed to develop a 
new preparation of curcumin, to enhance the absorption 
and pharmacological activity.
Some intents to improve the bioavailability of 
curcumin, such as the using of nanoparticles, liposomes, 
structural analogues and phospholipid complexes 
(Gupta, Patchva, Aggarwal, 2013). Phytosome is a 
technology, which incorporate natural product compound 
or extract into phospholipids to produce lipid compatible 
molecular complex and then increase their absorption and 
bioavailability. Marczylo have prepared a formulation 
of curcumin with phosphatidylcholine (phytosome 
curcumin) to increase its oral bioavailability. The author 
showed that the maximum plasma concentration and area 
under the plasma concentration time curve values for 
phytosome curcumin after administration were fivefold 
higher than the equivalent values seen after curcumin free 
in rats plasma (Marczylo et al., 2007). In other study, the 
bioavailability of phytosome curcumin was investigated 
in human clincal trial. Phytosome curcumin showed the 
total curcuminoid absorption was 29-fold higher than for 
its corresponding curcuminoid free. Interestingly, the main 
plasma curcuminoid after administration of phytosome 
curcumin was demethoxycurcumin, but not curcumin 
(Cuomo et al., 2011).
Many study has demonstrated that the main causes 
of the damage liver is linked to reactive oxygen species 
(ROS) (Jaeschke, Ramachandran 2011). ROS can attack 
to polyunsaturated fatty acids in cellular membranes, 
B. T. Tung, N. T. Hai, P. K. Son
Braz. J. Pharm. Sci. 2017;53(1):e16136Page 2 / 13
the proteins groups and DNA bases. The cells had to 
develop efficiency defense systems to prevent damages 
with their own antioxidant enzyme system. Paracetamol 
has been widely used in model of hepatotoxicity in 
mice (McGill et al., 2012). The biochemical changed 
with paracetamol toxicity seems to be a significantly 
increasing in serum alanine aminotransferase (ALT) and 
asparatate aminotransferase (AST) levels and decreasing 
the antioxidant enzyme endogenous in liver (Hinson, 
Roberts, James, 2010).
In our recent publication, we have prepared saponin-
phospholipids complex to increase the pharmacological 
effect of saponin having poor oral absorption (Kim et 
al., 2016). Continue studying to improve bioavailability 
of natural product, in this paper we aimed to prepare 
phytosome curcumin and determine its physicochemical 
characteristics and evaluate its hepatoprotective effect in 
paracetamol-induced mice, compare with curcumin free.
MATERIAL AND METHODS
Preparation of phytosome curcumin
Phytosome curcumin was prepared by reaction 
between curcumin and phosphatidylcholine at different 
molar ratios: 1:1; 1:2; 1:4, each ratio was repeated three 
times. Weigh exactly 2.04 g curcumin powder and 4.35 
g phosphatidylcholine and put to 100 mL round bottom 
flask, then added 30 mL of dichloromethane. The mixture 
was refluxed at 40 oC with magnetic stirring for 2 hours. 
Then solution was evaporated to remove dichloromethane 
and added 50 mL n-hexane. The obtained complex was 
precipitated, filtered and dried under vacuum to obtain the 
phytosome complex.
Morphology and structure of phytosome 
curcumin
Using the method of negative staining transmission 
electron microscopy (TEM) scanning electron microscope 
(SEM).
Determination of curcumin content in the 
phytosome curcumin
Standard curve of curcumin concentration
Approximately 100 mg curcumin powder was 
dissolved in methanol in 25 mL volumetric flask (4 mg/
mL). This solution was diluted 1000 – 10000x (4 µg/mL- 
0.4 µg/mL) and filtered through membrane 0.45 µm and 
prepared a standard curve of curcumin by using a HPLC 
method. The mobile phase used was water and acetonitrile 
gradient as following:
Mobil phase
Using water and acetonitrile gradient as following: 
Determination of curcumin content in the complex
Approximately 50 mg of phytosome was dissolved 
in methanol in 25 mLvolumetric flask (2 mg/mL). These 
solutions were diluted 1000x (2 µg/mL). This solution 
was filtered through membrane 0.45 µm and percentage 
of curcumin was determined by using the HPLC method 
as described above.
Yield of process
Weight exactly amount of phytosome, curcumin, 
disperse in water with 1:100 (w/v). Centrifugate at 8000 
rpm during 30 min. Filter, take the solid and disolve in 
methanol. Curcumin’s was concentration was determined 
by using a HPLC method.
Yield of process was calculated by: 
Infrared (IR) spectroscopy
Infrared spectrum of curcumin, phosphatidylcholine 
and phytosome was measured by Fourier transform 
infrared spectroscopy (FTIR). 
Differential scanning calorimetry (DSC)
The samples were sealed in the aluminum crimp 
cell and heated at the speed of 10 oC/min from 0 to 800 oC 
in nitrogen atmosphere (60 mL/min). The peak transition 
onset temperature of the obtained complexes were 
determined and compared with the help of a Mettler DSC 
30S (Mettler Toledo, US) (Shyam, Kumar, 2012).




Detector: UV –VIS, 425 nm. 
Flow rate: 1,0 mL/ min 
Injection volume: 10 µL
Column: Agilent ZORBAX Eclipse Plus 95Å C18, 4.6 x 
100 mm, diameter 3,5 µm. 
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1H-NMR Spectroscopy
1H-NMR (500 MHZ CDCl3, δ in ppm) spectroscopy 
of curcumin, phosphatidylcholine, and phytosome 
curcumin was carried out by using Brucker Advance 
DRX-500, BruckerBioSciences Corporation, Billerica, 
MA, USA) at 500 MHz (Maiti et al., 2007).
Particle Size and Zeta Potential analysis
The particle size and zeta potential of phytosome 
curcumin were determined at 25°C using photon 
correlation spectroscopy (ZetaSizer Nano-ZS90, Malvern, 
UK). The analysis consisted of 100 mg of phytosome 
curcumin powders were dispersed in about 15 mL of 
double-distilled water before analysis. 
Solubility studies
Solubility of curcumin, phytosome curcumin and 
physical mixture of curcumin and phosphatidylcholine were 
evaluated by adding excess of the samples to 5 mL of water 
in glass container at room temperature. The liquids were 
shaken for 24 h and centrifuged at 5000 rpm for 10 min. The 
supernatant was filtered by membrane 0,45μm. Dilute 1 mL 
with methanol to 10 mL and their curcumin’s concentration 
were measured by HPLC method (Maiti et al., 2007). 
Animals 
Fifty (25–30 g) Swiss mice were used to study the 
hepatoprotective activity of the phytosome curcumin. 
The animals were kept at 27 ± 2 °C, relative humidity 
44–56% and light and dark cycles of 12 h, for 5 days 
before and during the experiments. Animals were 
provided with standard diet and water ad libitum. Mice 
were randomly divided into five groups, each group 
consisting of ten mice. 
Group I received a single daily dose of 1 mL/kg of saline 
orally (NC group). 
Group II was given a single daily dosing of paracetamol 
(500 mg/kg) orally (PAR group). 
Group III was given orally a single daily dose of both 500 
mg/kg paracetamol and 200 mg/kg of Curcumin (CUR 
group).
Group IV was given orally a single daily dose of both 500 
mg/kg paracetamol and amount phytosome curcumin 
equivalent to curcumin 100 mg/kg b.w (Phyt 100 group).
Group V was given orally a single daily dose of both 500 
mg/kg paracetamol and amount phytosome curcumin 
equivalent to curcumin 200 mg/kg b.w (Phyt 200 group).
Phytosome curcumin was administered three hours 
after the administration of paracetamol. The treatments 
were continued for seven days and on the final day of 
the experiment blood were taken from carotid artery of 
all animals and then mice were sacrificed by cervical 
dislocation. All liver tissues were dissected, washed in 
0.9% NaCl and frozen rapidly at -80 °C. Frozen tissues 
defrosted, weighted and homogenized in ice-cold lysis 
buffer, containing 50 mM Tris-HCl (pH 7.5), 8 mM 
MgCl2, 5 mM ethylene glycol bis (2-aminoethyl ether)-
N,N,N’,N’-tetraacetic acid (EGTA), 0.5 mM EDTA, 0.01 
mg/mL leupeptin, 0.01 mg/mL pepstatin, 0.01 mg/mL 
aprotinin, 1 mM phenylmethylsulfonyl fluoride (PMSF) 
and 250 mM NaCl. Homogenates were then centrifuged 
at 12000 × g for 10 min at 4 °C. The supernatants 
was collected and stored until use at -80 oC. Protein 
concentration was determined by Bradford’s method 
(Noble, Bailey, 2009).
Hepatotoxicity
Serum levels of ALT and AST as markers of 
hepatic function were measured by using a ALT Activity 
Assay Kit and AST Activity Assay Kit (Sigma-Aldrich, 
Singapore) according to the manufacturer’s instructions.
Lipid peroxidation assay 
Lipid peroxidation assay was performed by 
determining the reaction of malonaldehyde with two 
molecules of 1-methyl-2-phenylindole at 45°C as 
described previously (Thanh et al., 2016; Thanh et al., 
2015). The reaction mixture consisted of 0.64 mL of 
10.3 mM 1-methyl-2-phenylindole, 0.2 mL of sample 
and 10 µL of 2 µg/mL butylated hydroxytoluene. After 
vigorously mixing, 0.15 mL of 37% v/v HCl was added. 
The mixture was incubated at 45°C for 45 min and 
centrifuged at 10,000 g for 10 min. Cleared supernatant 
absorbance was recorded at 586 nm. A calibration 
curve prepared from 1,1,3,3- tetramethoxypropane 
(Sigma-Aldrich, Singapore) was used for calculation. 
Peroxidized lipids were expressed as nmol MDA 
equivalents/mg protein.
Superoxide dismutase (SOD) activity 
determination
SOD activity was determined as described previously 
(Thanh et al., 2015). This method is based on the capacity 
of SOD to inhibit the autoxidation of pyrogallol. Each 
assay was measured in triplicate.
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Catalase (CAT) activity determination
CAT activity was measured in triplicate by 
monitoring the disappearance of H2O2 at 240 nm as 
described previously (Thanh et al., 2015). Each assay was 
measured in triplicate.
Glutathione peroxidase (GPx) activity 
determination
Glutathione peroxidase (GPx) activity was measured 
with a coupled enzyme assay described previously (Thanh 
et al., 2015). Each assay was measured in triplicate. 
Statistical analysis
All data are expressed as the mean ± standard 
deviation (SD). One-way analysis of variance (ANOVA) 
was used to determine significance among groups. 
Statistical significance was set at p<0.05. 
RESULTS
Physical properties of phytosome curcumin
The resultant complexes after dried under vacuum 
were kept in petri disk (Figure 1). All phytosomes 
have orange–yellow powders, but the phytosome 
with the ratio curcumin and phosphatidylcholine 1:1 
were softer and smoother while phytosome with ratio 
curcumin and phosphatidylcholine 1:2 and 1:4 seemed 
to be more sticky and clammy. That may be explained 
by the more presence of phosphatidylcholine in 
the samples. 
Morphology of phytosome curcumin
SEM and TEM images demonstrate the formation 
of particles. As shown in Figure 2 (A, B) the particles 
observed under SEM showed spherical-shaped particles. 
The TEM showed that particles phytosome curcumin are 
uniforms and homogeneous. 
Yield of phytosome preparation process 
Yield of phytosome preparation process was 
presented in Table I.
FIGURE 1 - Physical properties of curcumin phytosome at different ratios.
FIGURE 2 - Phytosome curcumin was taken by SEM 
(A) and TEM (B) of phytosome curcumin with curcumin: 
phosphatidylcholine ratio is 1:1.
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Table I showed that total yield of the preparation 
process increased following the rise of phosphatidylcholine 
amount added in the complexes. With the curcumin: 
phosphatidylcholine ratio is 1:2 and 1:4, the yield can be 
about 94%. However, this yield is only about 81% when 
the ratio is 1:1. This can be explained by adding the large 
amount of phosphatidylcholine, the ability of interaction 
between curcumin and phosphatidylcholine was higher, 
lead to form more phytosome curcumin complex.
Determination of curcumin content in the 
complex
The curcumin content in the phytosome was shown 
in Table II. 
The curcumin content in the complex was determined 
by HPLC method. A HPLC chromatographical of 
phytosome curcumin with curcumin: phosphatidylcholine 
ratio (mol:mol) 1:1 is shown in Figure 3. The percentages 
of curcumin in the phytosome in sample at ratio 1:1 
are higher than curcumin in other ratio. The amount 
of curcumin reached 25.64% in the complexes with 
curcumin: phospholipis ratio 1:1. However, curcumin 
content reached 12.61 % and 8.97 % in the complexes 
with 1:2 and 1:3 ratios, respectively.
Particles size and zeta potential of phytosome 
curcumin
The distribution of the size of phytosome curcumin 
was shown in Figure 4. The average size of phytosome 
curcumin was 131.8 nm and PDI was 0.191. The zeta 
potential of PEG-CUR was -44.5 mV. One important 
parameter of nanoparticles is the polydispersity index 
(PDI), which is measured the particle size distribution. If 
PDI is smaller than 0.1, the particles are typically referred 
to as “monodisperse” (Moreira, Gaspar, Allen, 2001; 
Pereira-Lachataignerais et al., 2006; Pham et al., 2015). 
Our particles of phytosome curcumin are shown to be 
TABLE I - Total yield of phytosome preparation process
Curcumin: 
phosphatidylcholine ratio Total yield (w/w,%)
1:1 87.74 ± 1.73 
1:2 91.61 ± 2.24
1:4 94.64 ± 2.64
TABLE II - Curcumin content in the phytosome 
Sample (curcumin:phosphatidylcholine ratio) 1:1 1:2 1:4
Curcumin content (%) 25.64 ± 2.01 12.61 ± 1.76 8.97 ± 1.25
FIGURE 3 - Representative chromatograms HPLC chromatographical of Phytosome curcumin with curcumin: phosphatidylcholine 
ratio (mol:mol) is 1:1.
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quite uniforms with PDI was 0.191 and have an average 
size of 131.8 nm.
The index used to evaluate the stability of particle 
system is zeta potential value. If the particles possess the 
absolute value of zeta potential greater than 30 mV, then 
the particle system is highly stable and able to prevent the 
aggregation of particles. If zeta potential values are in the 
range of 20-30 mV, the particle system is relatively stable 
(Eloy et al., 2014; Pham et al., 2015). Our PEG-CUR has 
zeta potential values of -44.5 mV, it can be considered they 
are a relatively stable system. 
Infrared (IR) spectroscopy
IR spectra of curcumin, phosphatidylcholine and 
phytosome are shown in Figure 5. The IR spectra of 
curcumin showed two peaks at λ 1625.99 and 1600.92 cm-1 
which represent for C=C and C=O bonds, but disappear 
FIGURE 4 - Distribution of PEG-CUR size (A) and zeta potential (B).
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FIGURE 5 - Infrared spectrum of curcumin, phosphatidylcholine and phytosome curcumin.
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in phytosome’s IR spectra. The peak at λ 1734.01 cm-1 
presents in both IR spectra of phosphatidylcholine and 
phytosome curcumin. Moreover, the peak at λ 3506.59 
cm-1 of OH group in curcumin structure and two peaks 
at λ 2916.37 and 2848.86 cm-1 in phosphatidylcholine 
structure are also presented in phytosome curcumin’s IR 
spectrum. Interestingly, there is a new peak at λ 3745.76 
cm-1 and some fluctuations appearing from 3200 to 
4000 cm-1 in phytosome’s IR spectrum. This confirms 
the presence of hydrogen bonds between curcumin and 
phosphatidylcholine. Therefore, it is suggested that 
in the phytosome, curcumin bounds to the polar head 
of phosphatidylcholine while the non–polar part of 
phosphatidylcholine still are freely and envelops the polar 
part containing curcumin molecules.
Differential scanning calorimetry (DSC)
Figure 6 reveals the DSC thermographs of curcumin 
(A), phosphatidylcholine (B) and phytosome curcumin (C). 
DSC spectrum of curcumin showed the onset temperature 
of the melting processes is 155.8172oC corresponds to 
peak at 185.0430 oC which is the curcumin‘s melting 
temperature. Phosphatidylcholine has a melting peak 
at 149.5276 oC corresponds to the temperature when 
hydrocarbon tails of phosphatidylcholine transform from 
gel state to liquid crystalline. DSC of phytosome curcumin 
do not present the endothermic peak of both curcumin and 
phosphatidylcholine. The melting peak of curcumin and 
phosphatidylcholine were completely disappeared. Instead, 
it showed new melting peaks with lower endothermic effect 
of phosphatidylcholine (onset temperature 131.4244 oC 
and meilting peak 116.6517 oC). This proves that curcumin 
reacts with phosphatidylcholine to form the chemical bonds 
between the OH in phenol group of curcumin structure with 
phosphatidylcholine‘s polar head. 
1H NMR spectroscopy
The  pro ton  NMR spec t rum of  curcumin , 
phosphatidylcholine and phytosome curcumin was 
represented in Figure 7. In 1H-NMR of phytosome 
curcumin signals at δ 0.876, 1.296 and 2.764 ppm showed 
that the signals of protons of methyl, methylene group 
of aliphatic side chain and methylene protons linked 
to–C(=O)–C group, respectively. They are characteristics 
of nonpolar portion of phosphatidylcholine molecule. 
The signal of protons at δ 5.334 ppm is due to signals of 
second methylene group proton near N atom (-CH2CH2N) 
of choline and signals at δ 3.362 ppm is due to protons 
of methyl group attached to N–atom of choline which 
represented a signal broadening due to their involvement 
in phytosome curcumin (Sikarwar et al., 2008). The 
FIGURE 6 - Differential scanning calorimetry (DSC) 
thermograph of curcumin (A), phosphatidylcholine (B) and 
phytosome curcumin (C).
Hepatoprotective effect of Phytosome Curcumin against paracetamol-induced liver toxicity in mice
Braz. J. Pharm. Sci. 2017;53(1):e16136 Page 9 / 13
protons signals at 5.779-5.983; 6.459-6.491; 6.926-6.942; 
7.049-7.052; 7.112-7.132 and 7.572-7.604 [m, ArH] are 
due to aromatic ring of curcumin. These data suggested 
that phenyl group of curcumin was complexed with 
choline part of phosphatidylcholine. 
Solubility studies
Solubility of curcumin, phytosome and physical 
mixture of curcumin and phosphatidylcholine in water0 
was shown in Table III.
Curcumin, a hydrophobic molecule, is practically 
insoluble in water, especially at pH 1.2. Therefore, 
curcumin has very low bioavailability; this is a barrier 
of using curcumin in clinical application. When pH was 
increased, curcumin’s solubility tends to increase but still 
is very low. Solubility of curcumin in n-octanol is also very 
low. Therefore, bioavailability of curcumin by oral via 
or derma via is extremely low. Phytosome curcumin can 
significantly improve solubility of curcumin in solution 
at different pH and also in n-octanol. Thereby phytosome 
curcumin can increase the partition coefficient O/W, lead 
curcumin easily to diffuse into the cell membrane, easily 
transferred from the aqueous phase to the lipid phase, then 
increasing its bioavaibility.
Biological activity 
Enzyme such as AST and ALT are main liver 
transaminases have been used for the assessment of liver 
damage (Howell et al., 2014).
Serum ALT and AST activities were significantly 
increased in PAR group as compared with control group 
(Table IV). When mice were treated with phytosome, the 
ALT and AST activities were significantly decreased as 
compared to the PAR group. These enzymes activities 
tended to decrease in Cur 200 group compared with PAR 
group.
Lipid peroxidation
The levels of lipid peroxidation product (MDA) 
from the liver tissues in the studied groups were shown 
in Table V and Figure 8. An increased in MDA level was 
observed significantly in the PAR group when compared 
with control group (p<0.05). A decreased in MDA levels 
were observed significantly in group of Phyt 100 and Phyt 
200 (p<0.05). The level of MDA tended to decrease in Cur 
200 group compared with PAR group.
Antioxidant enzyme analysis
We also determined the activities of several 
antioxidant enzymes including CAT, SOD and GPx in 
the liver tissue of control and experimental animals. The 
results were reported in Table V and Figures 9, 10 and 
11. Mice in PAR group showed a significant lower in the 
activities of these antioxidants compared with control 
group (p<0.05). Mice in groups Phyt 100 and Phyt 200 
exhibited significant increasing in the levels of CAT, 
FIGURE 7 - Proton NMR Spectrum of Curcumin (A), 
Phosphatidylcholine (B) and Phytosome curcumin (C).
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Curcumin 8,2 ± 3,1 3,1 ± 2,3 13,3 ± 1,4 21,7 ± 1,4 4,1 ± 3,7
Mixture of curcumin and 
phosphatidylcholine (ratio 1:1)
17,7 ± 2,4 10,1 ± 2,4 19,4 ± 2,8 30,1 ± 5,1 8,4 ± 1,6
Phytosome curcumin (ratio 1:1) 38,7 ± 1,4 20,7 ± 3,5 32,7 ± 4,3 60,1 ± 1,1 44,1 ± 1,8
TABLE IV - Effect of phytosome curcumin on liver marker enzymes
Parameters Control PAR Cur 200 Phyt 100 Phyt 200 
AST (IU/L) 38.24 ± 4.23 101.28 ± 11.25* 81.28 ± 12.27 47.25 ± 5.24# 41.25 ± 5. 32#
ALT (IU/L) 31.12 ± 5.21 97.67 ± 11.84* 68.58 ± 14.45 42.15 ± 6.38# 37.17 ± 3.25#
TABLE V - The effect of administration of phytosome curcumin on lipid peroxidation and antioxidant enzymes in mice liver tissue
Parameters Control PAR Cur 200 Phyt 100 Phyt 200 
MDA 0.52 ± 0.14 1.89 ± 0.15* 1.61 ± 0.13 1.42± 0.12# 1.28 ± 0.11#
SOD 0.573 ± 0.09 0.187 ± 0.08* 0.210 ± 0.07 0.282 ± 0.10# 0.362 ± 0.12#
CAT 298.87 ± 39.15 89.8 ± 13.19* 129.8 ± 14.21 165.15 ± 21.12# 196.12 ± 23.15#
GPx 25.35 ± 3.27 10.19 ± 2.32* 11.23 ± 3.18 13.68 ± 2.72 17.86 ± 4.54#
Value represents as mean ± S.D. *p < 0.05, significant difference compared with control group, #p < 0.05, significant difference 
compared with paracetamol group (n = 10).
SOD and GPx compared with PAR group (p<0.05). These 
enzymes activities tended to increase in Cur 200 group 
compared with PAR group.
DISCUSSION
Preparing new formulation for curcumin delivery is 
important because of many beneficial effect of curcumin. 
Curcumin has poor absorption because of its low solubility 
(Maiti et al., 2007). Phospholipids are now using in many 
application of drug delivery technology. The advantage 
of phospholipids is increasing solubilizing property of 
many natural products. In this study, we have developed 
successfully phytosome curcumin which can improve 
the bioavailability of curcumin. The physicochemical 
data showed that curcumin formed a complex with 
phosphatidylcholine by hydrogen bonds. We also 
showed that the phytosome has increased the solubility 
of curcumin in different medium.
Paracetamol have been used in many study for 
induce liver damage (Farghaly, Hussein 2010). Liver is 
the main organ in body, which metabolizes chemicals 
and drug. It has been well known that enzyme AST and 
ALT are markers of hepatocyte damage and the high level 
of AST and ALT is an important marker for liver injury 
(McGill, Jaeschke, 2013). In our study, paracetamol 
significant induced hepatic damage in mice by increasing 
the level of AST and ALT. Our data are agreed with 
Nithianantham et al. (2011) they have showed that 
parcetamol significant increased the ALT, AST, and 
bilirubin levels in mice.
Phytosome curcumin protects the mice from PAR-
induced acute liver injury in vivo. After administration of 
paracetamol, serum ALT and AST levels in mice were 
significantly greater than those in control group, and 
phytosome curcumin could reduce those levels. Our results 
indicate that phytosome curcumin protects hepatocytes in 
vivo from damage induced by paracetamol administration. 
Our data are in line with previous report that curcumin 
can protect damages in liver caused by paracetamol 
(Kheradpezhouh et al., 2010). 
When reactive oxidative stress attack polyunsaturated 
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FIGURE 8 - Effect of phytosome curcumin on lipid peroxidation 
of control and treated animals in paracetamol-induced liver 
injury in mice. NC: Control group; PAR: mice received 1g/
kg b.w of Paracetamol; CUR: mice received 200 mg/kg b.w 
curcumin and 1g/kg b.w of Paracetamol; Phyt 100: mice 
received amount phytosome curcumin equivalent to curcumin 
100 mg/kg b.w and 1g/kg b.w of Paracetamol; Phyt 200: mice 
received amount phytosome curcumin equivalent to curcumin 
200 mg/kg b.w and 1g/kg b.w of Paracetamol; Value represents 
as mean ± S.D. *p<0.05, significant difference compared with 
control group, #p < 0.05, significant difference compared with 
paracetamol group (n = 10).
FIGURE 9 - Effect of phytosome curcumin on CAT activity of 
control and treated animals in paracetamol-induced liver injury 
in mice. Value represents as mean ± S.D. *p<0.05, significant 
difference compared with control group, #p<0.05, significant 
difference compared with paracetamol group (n = 10).
FIGURE 10 - Effect of phytosome curcumin on SOD activity of 
control and treated animals in paracetamol-induced liver injury 
in mice. Value represents as mean ± S.D. *p<0.05, significant 
difference compared with control group, #p<0.05, significant 
difference compared with paracetamol group (n = 10).
FIGURE 11 - Effect of phytosome curcumin on GPx activity of 
control and treated animals in paracetamol-induced liver injury 
in mice. Value represents as mean ± S.D. *p<0.05, significant 
difference compared with control group, #p<0.05, significant 
difference compared with paracetamol group (n = 10).
fatty acids and disrupt the cell membrane. It leads to 
oxidative lipid and forms MDA, a product of lipid 
peroxidation. Increasing production of liver MDA observed 
in our experiments by PAR are in agreement with previous 
study which reported that PAR increased extracellular 
MDA level (Boonruamkaew, Chonpathompikunlert et al., 
2016). In addition, we have shown phytosome curcumin 
may diminish the level of MDA in liver tissues. Our data are 
in line with study of Hatem et al. which showed that hepatic 
lipid peroxidation level was suppressed by administration 
of curcumin to paracetamol-treated rats (Farghaly, Hussein 
2010).
The organism can develop a mechanism, such as 
the antioxidant system SOD, CAT and GPx to decrease 
the damage cause by ROS. SOD, CAT and GPx are 
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endogenous enzymatic against ROS. SOD is antioxidant 
enzyme that converts superoxide anion O2
•- to H2O2. 
CAT converts H2O2 to water and O2. GPx catalyzes the 
reduction of H2O2 and other peroxides by coupling reduced 
glutathione (Madrigal-Santillan et al., 2014; Thanh et 
al., 2015). Our data have showed the activities of these 
enzymes in PAR group were declined. Interestingly 
when mice were treated with phytosome curcumin, these 
enzymes can be reversed significantly. 
The hepatoprotective effect of phytosome was 
significantly higher than curcumin free at the same dose. 
Free curcumin at the dose of 200 mg/kg only slightly 
reduced the damage conditions in mice induced by 
paracetamol. The phytosome at dose equivalent to 100 
mg/kg of curcumin showed higher restored the damage 
of mice liver compared with curcumin free at double dose 
(200 mg/kg). The increasing hepatoprotective efficacy 
of phytosome curcumin may be explained by increasing 
bioavailability of the curcumin.
In summary,  this  s tudy demonstrates  that 
phytosome curcumin had a strong protective effect against 
paracetamol-induced acute hepatic damage in mice. The 
hepatoprotective effect of phytosome curcumin may be 
explained by increasing levels of antioxidant enzymes 
and decreasing the lipid peroxidation and liver enzyme 
on paracetamol-induced damage in mice. 
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